) This proposal is for the Comprehensive Cancer Center Biostatistics Unit at the University of Alabama at Birmingham (UAB) to serve as the Operations, Statistical and Data Management Center (OMC) for the AIDS-Associated Malignancies Clinical Trials Consortium. The purpose of the Consortium is to design and conduct clinical trials with novel agents or innovative approaches in patients with AIDS-associated malignancies, primarily Non-Hodgkin's Lymphoma (NHL), Kaposi's sarcoma (KS), Hodgkin's disease, anogenital dysplasia, anal and cervical cancer. It is anticipated that the Consortium will perform four to six clinical trials and enroll 200 patients per year with AIDS-associated malignancies from 8 to 10 clinical centers. The OMC will centralize many activities of the clinical trials, and will serve as the communications hub for the Consortium. The OMC will provide statistical expertise to the Consortium in the areas of study design, sample size, and analyses; coordinate the development, submission, conduct and analysis of protocols undertaken by the Consortium; establish and implement quality control procedures; monitor the conduct of the clinical trials; establish and implement procedures for data management; maintain the database for the clinical trials; perform all statistical analyses; manage the Discretionary Fund; coordinate the acquisition and shipping of specimens and relevant clinical data to the Tissue and Biological Fluids Banks of HIV- Associated Malignancies; and provide administrative support for the study. The Biostatistics Unit has considerable experience in serving as the statistical coordinating center for multicenter clinical trials groups. The location of all personnel involved in coordinating center activities in one physical location is both cost and time efficient. With both an NIH-funded Comprehensive Cancer Center and Center for AIDS Research at UAB, expertise in the medical, virologic, oncologic, immunologic, epidemiologic, and behavioral areas will be available to the OMC on an ongoing basis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA070019-04
Application #
2748831
Study Section
Special Emphasis Panel (SRC (09))
Program Officer
Wu, Roy S
Project Start
1995-09-30
Project End
1999-07-31
Budget Start
1998-08-01
Budget End
1999-07-31
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Noy, Ariela; Lensing, Shelly Y; Moore, Page C et al. (2016) Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leuk Lymphoma 57:1731-4
Lechowicz, Maryjo; Dittmer, Dirk P; Lee, Jeannette Y et al. (2009) Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid. Clin Infect Dis 49:1946-9
Lin, Lan; Lee, Jeannette Y; Kaplan, Lawrence D et al. (2009) Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood. J Clin Oncol 27:2496-502
van der Burg, Sjoerd H; Palefsky, Joel M (2009) Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful. J Transl Med 7:108
Ratner, Lee; Harrington, William; Feng, Xuan et al. (2009) Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. PLoS One 4:e4420
Spitzer, Thomas R; Ambinder, Richard F; Lee, Jeannette Y et al. (2008) Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Biol Blood Marrow Transplant 14:59-66
Brinker, Brett T; Krown, Susan E; Lee, Jeannette Y et al. (2008) Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium. Cancer 112:1083-8
Stier, Elizabeth A; Goldstone, Stephen E; Berry, J Michael et al. (2008) Infrared coagulator treatment of high-grade anal dysplasia in HIV-infected individuals: an AIDS malignancy consortium pilot study. J Acquir Immune Defic Syndr 47:56-61
Noy, Ariela; von Roenn, Jamie; Politsmakher, Alex et al. (2007) Fatal hepatorenal failure and thrombocytopenia with SU5416, a vascular endothelial growth factor Flk-1 receptor inhibitor, in AIDS-Kaposi's sarcoma. AIDS 21:113-5
Krown, Susan E; Lee, Jeannette Y; Lin, Lan et al. (2006) Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial. J Acquir Immune Defic Syndr 41:149-53

Showing the most recent 10 out of 20 publications